Purchase Order 75N91023P00541

Award Date 6/27/23
Potential Completion Date 6/26/25
Potential Value $247K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI) awarded a $250,000 firm fixed-price purchase order to Baylor College of Medicine to establish the U.S. Pediatric Proton and Photon Therapy Cohort, a retrospective study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated at their institution with proton or photon therapy....
The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
The National Cancer Institute (NCI) has awarded a $249,814 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for the US Pediatric Proton and Photon Therapy Cohort study. This retrospective cohort study aims to compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) to The University of Texas MD Anderson Cancer Center (MD Anderson) for $972,225.00 to provide medical physics peer review of radiation therapy quality assurance operations. The contract has a firm fixed price structure and a period of performance through March 12, 2025. MD Anderson is a child entity of the University of Texas System, which has a history of receiving federal contracts and grants across various...
The National Institutes of Health's National Cancer Institute awarded a $249,323 firm fixed price purchase order to The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital. This contract is to serve as the Pediatric Proton and Photon Therapy Comparison Cohort Coordinating Center. Per the statement of work, the center will coordinate data collection and analysis from multiple pediatric cancer treatment sites comparing outcomes of patients...
The National Cancer Institute (NCI) awarded a $293,970 firm fixed-price purchase order to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to retrieve existing clinical and treatment data for at least 500 pediatric cancer patients treated with photon therapy since 2007. This data will be used to evaluate photon therapy as a cancer treatment for pediatric patients as part of the U.S. Pediatric Photon Therapy Comparison Cohort Study. The...
This federal contract award, valued at $478,008.47, was granted by the National Aeronautics and Space Administration (NASA) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract aims to acquire data on neurocognitive/behavioral impairments and associated biomarkers observed in patients undergoing cranial exposure to ionizing radiation, with a focus on non-invasive imaging modalities and serum biomarkers. This work will provide benchmark...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Cancer Institute to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit hospital and research institution. The $249,997.00 contract will obtain data on a cohort of pediatric cancer patients treated with proton therapy and a comparison group treated with photon therapy, to serve as part of a...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute to The Washington University for $249,997 to provide medical record abstraction services in support of a study comparing pediatric proton and photon radiation therapy. The 14-month contract does not have a set-aside designation. The services will involve retrieving de-identified clinical and treatment data from medical records of pediatric cancer patients treated with proton or photon radiotherapy. This contract...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to retrieve existing clinical and treatment data for pediatric cancer patients treated with photon therapy at the university's institution. The $118,611.00 contract is part of the US Pediatric Photon Therapy Comparison Cohort Study, a program focused on...

This federal contract award was made by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The contract, valued at $247,116.20, is for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. MD Anderson will retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with proton or photon therapy at their institution. This data will be used to evaluate second cancer risks and other adverse effects associated with these radiation therapy methods. There is no set-aside designation for this contract. The research effort builds upon the US Pediatric Proton Consortium Registry, which has recruited over 3,000 pediatric proton patients since 2012. This contract represents part of NCI's efforts to address concerns about potential side effects of proton therapy and quantify the risks and benefits compared to traditional photon radiation therapy in the pediatric cancer population.

Generated 6/21/24, 9:33 AM